SIRTeam
Home
About
Research
Members
Works
Publications
Projects
Theses
Announcements
Contact
Türkçe
SIRTeam
.
.
News
12/29/2020
Recently published!
Recent Publications
<i>In silico</i> approach reveals <i>N</i>-(5-phenoxythiophen-2-yl)-2-(arylthio)acetamides as promising selective SIRT2 inhibitors: the case of structural optimization of virtual screening-derived hits
GÖZELLE M.
,
BAKAR ATEŞ F.
,
Massarotti A.
,
Ozkan E.
,
Gunindi H. B.
,
ÖZKAN Y.
, et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2023 (SCI-Expanded)
Selective inhibition of SIRT2: A disputable therapeutic approach in cancer therapy
KAYA S. G.
,
EREN G.
BIOORGANIC CHEMISTRY, vol.143, pp.107038-0, 2024 (SCI-Expanded)
Field-based 3D-QSAR studies on amide- and urea-containing NAMPT inhibitors
ÖZGENCİL F.
,
EREN G.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS, vol.242, 2023 (SCI-Expanded)
3D-QSAR Studies on Amide and Urea Derivatives as NAMPT Inhibitors
ÖZGENCİL F.
,
EREN G.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, France, 8 - 09 September 2022
In Silico Hit Optimization toward SIRT2 Inhibition: N-aryloxyaryl-2-(arylthio)acetamides
KAYA S. G.
,
ÖZKAN Y.
,
EREN G.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, France, 8 - 09 September 2022
N-(5-(3-Methoxybenzyl)/(pyrimidin-2-yl-methyl))-1,3,4-oxadiazol-2-yl)-2-(arylthio)acetamide Derivatives as SIRT2 Inhibitors
AKSEL A. B.
,
ÖZKAN Y.
,
EREN G.
9th EFMC Young Medicinal Chemists' Symposium (EFMC-YMCS 2022), Nice, France, 8 - 09 September 2022
Ariloksi Benzamit Yapısında Sirtuin İnhibitörü Olabilecek Bileşiklerin Tasarımı, Sentezi ve Biyolojik Aktivite Çalışmaları
YAĞCI S.
,
GÖZELLE M.
,
ÖZKAN Y.
,
BAKAR ATEŞ F.
,
EREN G.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Turkey, 26 - 29 August 2022
Yeni Nikotinamit Fosforiboziltransferaz (NAMPT) İnhibitör Adaylarının Sanal Tarama Yöntemi ile Keşfi ve Biyolojik Etkilerinin Belirlenmesi
ÖZGENCİL F.
,
ÖZKAN Y.
,
EREN G.
VI. Ulusal Farmasötik Kimya Kongresi, İstanbul, Turkey, 26 - 29 August 2022
Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity
Gözelle M.
,
Kaya S. G.
,
Aksel A. B.
,
Özkan E.
,
Bakar Ateş F.
,
Özkan Y.
, et al.
Bioorganic Chemistry, vol.123, pp.105746, 2022 (SCI-Expanded)
Discovery of 5-Benzyl-1,3,4-oxadiazole/thiadiazole-2-carboxamides as Potential Leads for Selective SIRT2 Inhibition
GÖZELLE M.
,
ÖZKAN Y.
,
EREN G.
GPSS-2021, 3rd International Gazi Pharma Symposium Series, Ankara, Turkey, 8 - 10 September 2021